Partners PrEP sub-study finds no evidence that PrEP use is associated with risk compensation behaviour

How useful is pre-exposure prophylaxis (PrEP)?  The Partners PrEP randomized control study of daily pre-exposure prophylaxis among HIV-uninfected partners of heterosexual HIV-discordant couples in Uganda and Kenya has indicated that, given adequate adherence, PrEP has high biologic efficacy.  The study itself (Baeten & Celum) demonstrates levels of risk reduction of 75%; while a spin-off sub-study […]

Read More…

HIV+ mothers without ART: when and how should they wean?

Without antiretrovirals, breastfeeding contributes 28% to the risk of mother-to-child HIV transmission (MTCT) (http://sti.bmj.com/content/88/Suppl_2/i44.abstract?sid=fcfaeecc-767f-4db8-b644-77db5aa8db63).  Antiretroviral drugs make achieving he WHO goal of near elimination of MTCT imaginable (http://sti.bmj.com/content/87/3/261.full; http://sti.bmj.com/content/86/Suppl_2/ii48.abstract?sid=fcfaeecc-767f-4db8-b644-77db5aa8db63).  But, in the meantime, what advice should be given to HIV+ mothers in those low-resource settings where antiretrovirals are still not available? In this context, the […]

Read More…

The dapivirine ring: success at last for a vaginal microbicide?

The International Partnership for Microbicides (IPM) has just announced the launch of a trial (IPM 027) to evaluate the effectiveness of the antiretroviral (ARV) drug dapivirine delivered by means of a monthly replaceable vaginal ring (http://www.ipmglobal.org/node/670).  The IPM study, which has enrolled 1,650 women at four sites in South Africa, is part of a broader […]

Read More…

HIV and breastfeeding in Africa: balancing the risks

One area in which the recent wide scale deployment of ARV could have the greatest impact is that of mother-to-child HIV transmission (PMTCT).  The UNAIDS goal is for total elimination of PMTCT by 2015 – though this is scarcely feasible (STI 2010:86 Suppl.II – especially M. Mahy et al. (http://sti.bmj.com/content/86/Suppl_2/ii48.full?sid=50f44956-1266-4dd0-bed1-08ebd39bb60a)).  A component of the PMTCT […]

Read More…

How infectious are HIV+ MSM on ART?

How effective is HAART (highly active antiretroviral therapy) in preventing HIV transmission among MSM (men who have sex with men)?  The recent HPTN (HIV Prevention Trials Network) 052 clinical trial demonstrated, to great acclaim, that with heterosexual sero-discordant couples early initiation of HAART is associated with 96% reduction in HIV transmission.  Yet there are reasons […]

Read More…

Modelling ART impact on HIV prevention within discordant couples

The HPTN 052 study, discussed in an earlier blog, appears to offer a godsend:  a demonstrated 96% reduction in HIV transmission in discordant couples using antiretroviral therapy (ART).   Apparently, the extension of ART conveys an additional, and unexpected, benefit in its potential impact on prevention.  But how do we quantify the additional benefit? A recent […]

Read More…

Costing the scale-up of voluntary medical male circumcision

The end of November saw the first in a series of nine new articles produced by researchers associated with the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United States President’s Emergency Plan of AIDS Relief (PEPFAR).  This article proposes a rapid (five-year) scale-up of voluntary medical male circumcision (VMMC) in 13 priority sub-Saharan […]

Read More…